Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Non-Current Deffered Revenue (2016 - 2019)

Historic Non-Current Deffered Revenue for Forte Biosciences (FBRX) over the last 4 years, with Q1 2019 value amounting to -$2.3 million.

  • Forte Biosciences' Non-Current Deffered Revenue fell 153687.5% to -$2.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$2.3 million, marking a year-over-year decrease of 153687.5%. This contributed to the annual value of $2.2 million for FY2018, which is 601388.89% up from last year.
  • Per Forte Biosciences' latest filing, its Non-Current Deffered Revenue stood at -$2.3 million for Q1 2019, which was down 153687.5% from $2.2 million recorded in Q4 2018.
  • Forte Biosciences' Non-Current Deffered Revenue's 5-year high stood at $2.2 million during Q4 2018, with a 5-year trough of -$2.3 million in Q1 2019.
  • Moreover, its 4-year median value for Non-Current Deffered Revenue was $64500.0 (2016), whereas its average is $389600.0.
  • In the last 5 years, Forte Biosciences' Non-Current Deffered Revenue soared by 601388.89% in 2018 and then tumbled by 153687.5% in 2019.
  • Over the past 4 years, Forte Biosciences' Non-Current Deffered Revenue (Quarter) stood at $68000.0 in 2016, then crashed by 47.06% to $36000.0 in 2017, then skyrocketed by 6013.89% to $2.2 million in 2018, then tumbled by 204.45% to -$2.3 million in 2019.
  • Its last three reported values are -$2.3 million in Q1 2019, $2.2 million for Q4 2018, and $2.0 million during Q3 2018.